CAS: 1655504-04-3
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide REF: AN-AG01KFHUCAS: 1655504-04-3 | 98% | 187,00 €~607,00 € | Mer 08 Mag 24 |
 | Orelabrutinib REF: TM-T12317CAS: 1655504-04-3 | 99.44% | 89,00 €~1.859,00 € | Mer 08 Mag 24 |
 | Orelabrutinib REF: 3D-FRC50404CAS: 1655504-04-3 | Min. 95% | 105,00 €~587,00 € | Mar 21 Mag 24 |
![6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide](https://static.cymitquimica.com/products/AN/thumb/AG01KFHU.jpg)
6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide
CAS:1655504-04-3
Formula:
C26H25N3O3
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
427.4950
Ref: AN-AG01KFHU
| 25mg | 187,00 € | |
| 50mg | 224,00 € | |
| 100mg | 506,00 € | |
| 250mg | 607,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 08 Maggio 2024
Orelabrutinib
CAS:1655504-04-3
Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).
Formula:
C26H25N3O3
Purezza:
99.44%
Colore e forma:
Solid
Peso molecolare:
427.49
Ref: TM-T12317
| 1mg | 89,00 € | |
| 5mg | 184,00 € | |
| 10mg | 309,00 € | |
| 25mg | 511,00 € | |
| 50mg | 707,00 € | |
| 100mg | 925,00 € | |
| 500mg | 1.859,00 € | |
| 1ml*10 (DMSO) | 212,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 08 Maggio 2024
Orelabrutinib
CAS:1655504-04-3
Orelabrutinib is a potent inhibitor of Bruton's tyrosine kinase (BTK). It has been shown to …
Formula:
C26H25N3O3
Purezza:
Min. 95%
Peso molecolare:
427.5 g/mol
Ref: 3D-FRC50404
| 5mg | 105,00 € | |
| 10mg | 156,00 € | |
| 25mg | 281,00 € | |
| 50mg | 396,00 € | |
| 100mg | 587,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Maggio 2024
